Abnormal arm swing movements in Parkinson's disease: onset, progression and response to L-Dopa.
M Patera, A Zampogna, L Pietrosanti and 13 others
PMID 40038703WHAT IT FOUND
Arm swing was reduced and less smooth in Parkinson's disease, even before levodopa.
Levodopa improved shoulder swing range and speed and forearm smoothness, but not asymmetry. Clinicians should watch early arm swing asymmetry during walking.
Key findings
01Patients with Parkinson's disease had lower arm swing range and speed than healthy controls, and the difference was already present in drug-naive early PD.
02In mid-advanced Parkinson's disease, the L-Dopa ON state increased shoulder arm swing range and speed and reduced forearm distortion, but did not change asymmetry or elbow measures.
03Shoulder arm swing asymmetry was higher in early Parkinson's disease than in healthy controls, but not in mid-advanced PD OFF state.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was cross-sectional, so it cannot show how arm swing changes over time in the same patients. The sample was 40 PD patients and 20 healthy controls, with only 20 in each patient subgroup. The walking test was performed under direct observation, so participants may have paid more attention to their movement than at home. The paper did not systematically collect nuclear medicine measures, so its dopaminergic pathway explanation is not proven. Some forearm asymmetry comparisons lost significance after correction for multiple comparisons.
Declared interests
The paper names PNNR Europe as funder. No other conflict of interest statement is given in the supplied text.
The easy way to misread this
Do not read the paper as showing that arm swing steadily worsens with Parkinson's disease stage. The more affected side did not differ between early PD and mid-advanced PD OFF state.